Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Drug repurposing). Showing records 1 – 30 of 49 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

Levels

Country

▼ Search Limiters


University of Utah

1. Gibson, Christopher C. Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting.

Degree: PhD, Bioengineering, 2014, University of Utah

 Destabilization of the endothelial monolayer lining blood vessels has profound consequences onorganismal homeostasis. Vascular instability plays a well-known role in the pathophysiology of diseasesfrom sepsis… (more)

Subjects/Keywords: Drug discovery; Drug repurposing; Endothelium; High-content; Screening; Stroke

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gibson, C. C. (2014). Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting. (Doctoral Dissertation). University of Utah. Retrieved from http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282

Chicago Manual of Style (16th Edition):

Gibson, Christopher C. “Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting.” 2014. Doctoral Dissertation, University of Utah. Accessed January 23, 2021. http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282.

MLA Handbook (7th Edition):

Gibson, Christopher C. “Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting.” 2014. Web. 23 Jan 2021.

Vancouver:

Gibson CC. Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting. [Internet] [Doctoral dissertation]. University of Utah; 2014. [cited 2021 Jan 23]. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282.

Council of Science Editors:

Gibson CC. Identification of novel treatments for a hereditary stroke disorder using quantitative phenotypic fingerprinting. [Doctoral Dissertation]. University of Utah; 2014. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/3501/rec/1282


University of Toronto

2. Wilson, Taylor Marie. Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme.

Degree: 2020, University of Toronto

Glioblastoma multiforme is an aggressive brain tumour characterized by poor prognosis, with overall patient survival rates averaging less than 15 months. Current treatment methods display… (more)

Subjects/Keywords: Cancer; Chemotherapy; Cholesterol; Drug Discovery; Drug Repurposing; Glioblastoma; 0379

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wilson, T. M. (2020). Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/103133

Chicago Manual of Style (16th Edition):

Wilson, Taylor Marie. “Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme.” 2020. Masters Thesis, University of Toronto. Accessed January 23, 2021. http://hdl.handle.net/1807/103133.

MLA Handbook (7th Edition):

Wilson, Taylor Marie. “Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme.” 2020. Web. 23 Jan 2021.

Vancouver:

Wilson TM. Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme. [Internet] [Masters thesis]. University of Toronto; 2020. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/1807/103133.

Council of Science Editors:

Wilson TM. Identifying Novel Targets in Chemo-resistant Cell Populations in Glioblastoma Multiforme. [Masters Thesis]. University of Toronto; 2020. Available from: http://hdl.handle.net/1807/103133


Virginia Commonwealth University

3. Wang, Chen. High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome.

Degree: PhD, Computer Science, 2018, Virginia Commonwealth University

  Drugs exert their (therapeutic) effects via molecular-level interactions with proteins and other biomolecules. Computational prediction of drug-protein interactions plays a significant role in the… (more)

Subjects/Keywords: drug-protein interactions; computational prediction; drug target database; drug repurposing; drug side-effects; Bioinformatics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, C. (2018). High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509

Chicago Manual of Style (16th Edition):

Wang, Chen. “High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome.” 2018. Doctoral Dissertation, Virginia Commonwealth University. Accessed January 23, 2021. https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509.

MLA Handbook (7th Edition):

Wang, Chen. “High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome.” 2018. Web. 23 Jan 2021.

Vancouver:

Wang C. High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2018. [cited 2021 Jan 23]. Available from: https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509.

Council of Science Editors:

Wang C. High-throughput prediction and analysis of drug-protein interactions in the druggable human proteome. [Doctoral Dissertation]. Virginia Commonwealth University; 2018. Available from: https://doi.org/10.25772/E2X0-B462 ; https://scholarscompass.vcu.edu/etd/5509


University of Rochester

4. Butts, Arielle Marie (1989 - ). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents.

Degree: PhD, 2014, University of Rochester

 Cryptococcus neoformans is an opportunistic human fungal pathogen that is capable of causing life-threatening infections. These infections generally occur in individuals with compromised immunity such… (more)

Subjects/Keywords: Antifungal; Cryptococcus; Drug discovery; Mode of action; Repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Butts, A. M. (. -. ). (2014). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents. (Doctoral Dissertation). University of Rochester. Retrieved from http://hdl.handle.net/1802/28300

Chicago Manual of Style (16th Edition):

Butts, Arielle Marie (1989 - ). “Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents.” 2014. Doctoral Dissertation, University of Rochester. Accessed January 23, 2021. http://hdl.handle.net/1802/28300.

MLA Handbook (7th Edition):

Butts, Arielle Marie (1989 - ). “Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents.” 2014. Web. 23 Jan 2021.

Vancouver:

Butts AM(-). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents. [Internet] [Doctoral dissertation]. University of Rochester; 2014. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/1802/28300.

Council of Science Editors:

Butts AM(-). Repurposing triphenylethylene estrogen receptor antagonists as anticryptococcal agents. [Doctoral Dissertation]. University of Rochester; 2014. Available from: http://hdl.handle.net/1802/28300


Texas A&M University

5. Sundararajan Venkatasubramani, Priyadharshini. Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data.

Degree: PhD, Electrical Engineering, 2017, Texas A&M University

 Scientific and technological advancements over the years have made curing, preventing or managing all diseases, a goal that seems to be within reach. The approach… (more)

Subjects/Keywords: plant pathogen interactions; metformin; RNA sequencing; drug repurposing; bayesian networks

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sundararajan Venkatasubramani, P. (2017). Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data. (Doctoral Dissertation). Texas A&M University. Retrieved from http://hdl.handle.net/1969.1/165919

Chicago Manual of Style (16th Edition):

Sundararajan Venkatasubramani, Priyadharshini. “Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data.” 2017. Doctoral Dissertation, Texas A&M University. Accessed January 23, 2021. http://hdl.handle.net/1969.1/165919.

MLA Handbook (7th Edition):

Sundararajan Venkatasubramani, Priyadharshini. “Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data.” 2017. Web. 23 Jan 2021.

Vancouver:

Sundararajan Venkatasubramani P. Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data. [Internet] [Doctoral dissertation]. Texas A&M University; 2017. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/1969.1/165919.

Council of Science Editors:

Sundararajan Venkatasubramani P. Bayesian Network Modeling and Inference in Plant Gene Networks And Analysis of Sequencing and Imaging Data. [Doctoral Dissertation]. Texas A&M University; 2017. Available from: http://hdl.handle.net/1969.1/165919


University of Toronto

6. Yun, Junghwa. Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens.

Degree: 2017, University of Toronto

Phosphoenolypyruvate carboxykinase (PEPCK) is the rate limiting enzyme in hepatic gluconeogenesis, which produces glucose from pyruvate to maintain circulating glucose level according to the bodyâ… (more)

Subjects/Keywords: Diabetes; Drug repurposing; Gluconeogenesis; Pck1; Pyruvate tolerance test; Zebrafish; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yun, J. (2017). Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/97184

Chicago Manual of Style (16th Edition):

Yun, Junghwa. “Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens.” 2017. Masters Thesis, University of Toronto. Accessed January 23, 2021. http://hdl.handle.net/1807/97184.

MLA Handbook (7th Edition):

Yun, Junghwa. “Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens.” 2017. Web. 23 Jan 2021.

Vancouver:

Yun J. Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/1807/97184.

Council of Science Editors:

Yun J. Validation and Mechanistic Studies of Gluconeogenesis Regulators Identified from Zebrafish Chemical Genetic Screens. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/97184


University of Cambridge

7. Donertas, Handan Melike. Computational studies on ageing and age-related diseases.

Degree: PhD, 2020, University of Cambridge

 Age is the major risk factor for a variety of non-communicable diseases. As life expectancy increases, ageing poses significant challenges to the individual, society, and… (more)

Subjects/Keywords: ageing; age-related diseases; drug repurposing; transcriptomics; GWAS

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Donertas, H. M. (2020). Computational studies on ageing and age-related diseases. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/311350

Chicago Manual of Style (16th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Doctoral Dissertation, University of Cambridge. Accessed January 23, 2021. https://www.repository.cam.ac.uk/handle/1810/311350.

MLA Handbook (7th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Web. 23 Jan 2021.

Vancouver:

Donertas HM. Computational studies on ageing and age-related diseases. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Jan 23]. Available from: https://www.repository.cam.ac.uk/handle/1810/311350.

Council of Science Editors:

Donertas HM. Computational studies on ageing and age-related diseases. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/311350


University of Cambridge

8. Donertas, Handan Melike. Computational studies on ageing and age-related diseases.

Degree: PhD, 2020, University of Cambridge

 Age is the major risk factor for a variety of non-communicable diseases. As life expectancy increases, ageing poses significant challenges to the individual, society, and… (more)

Subjects/Keywords: ageing; age-related diseases; drug repurposing; transcriptomics; GWAS

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Donertas, H. M. (2020). Computational studies on ageing and age-related diseases. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164

Chicago Manual of Style (16th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Doctoral Dissertation, University of Cambridge. Accessed January 23, 2021. https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164.

MLA Handbook (7th Edition):

Donertas, Handan Melike. “Computational studies on ageing and age-related diseases.” 2020. Web. 23 Jan 2021.

Vancouver:

Donertas HM. Computational studies on ageing and age-related diseases. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Jan 23]. Available from: https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164.

Council of Science Editors:

Donertas HM. Computational studies on ageing and age-related diseases. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://doi.org/10.17863/CAM.58440 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.818164


University of Manchester

9. Taylor, Jessica Tanya. High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme.

Degree: 2019, University of Manchester

 Glioblastoma Multiforme is the most common adult primary brain tumour, with median survival rates of around 15 months. The aggressive and heterogeneous nature of this… (more)

Subjects/Keywords: glioblastoma; neuro oncology; drug repurposing; personalised medicine; drug screening; mouse models; brain tumours; cancer research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Taylor, J. T. (2019). High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176

Chicago Manual of Style (16th Edition):

Taylor, Jessica Tanya. “High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Doctoral Dissertation, University of Manchester. Accessed January 23, 2021. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176.

MLA Handbook (7th Edition):

Taylor, Jessica Tanya. “High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Web. 23 Jan 2021.

Vancouver:

Taylor JT. High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme. [Internet] [Doctoral dissertation]. University of Manchester; 2019. [cited 2021 Jan 23]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176.

Council of Science Editors:

Taylor JT. High throughput screening of patient specific tumour cells: towards personalised treatment in recurrent glioblastoma multiforme. [Doctoral Dissertation]. University of Manchester; 2019. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:319176


University of Melbourne

10. Hameed, Pathima Nusrath. In silico methods for drug repositioning and drug-drug interaction prediction.

Degree: 2018, University of Melbourne

Drug repositioning and drug-drug interaction (DDI) prediction are two fundamental applications having a large impact on drug development and clinical care. Drug repositioning aims to… (more)

Subjects/Keywords: drug repurposing; biomedical informatics; DDI prediction; drug-target prediction; heterogeneous data integration; cluster evaluation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hameed, P. N. (2018). In silico methods for drug repositioning and drug-drug interaction prediction. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/219484

Chicago Manual of Style (16th Edition):

Hameed, Pathima Nusrath. “In silico methods for drug repositioning and drug-drug interaction prediction.” 2018. Doctoral Dissertation, University of Melbourne. Accessed January 23, 2021. http://hdl.handle.net/11343/219484.

MLA Handbook (7th Edition):

Hameed, Pathima Nusrath. “In silico methods for drug repositioning and drug-drug interaction prediction.” 2018. Web. 23 Jan 2021.

Vancouver:

Hameed PN. In silico methods for drug repositioning and drug-drug interaction prediction. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/11343/219484.

Council of Science Editors:

Hameed PN. In silico methods for drug repositioning and drug-drug interaction prediction. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/219484


University of Manchester

11. Taylor, Jessica. High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme.

Degree: PhD, 2019, University of Manchester

 Glioblastoma Multiforme is the most common adult primary brain tumour, with median survival rates of around 15 months. The aggressive and heterogeneous nature of this… (more)

Subjects/Keywords: mouse models; cancer research; brain tumours; drug screening; personalised medicine; drug repurposing; neuro oncology; glioblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Taylor, J. (2019). High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321

Chicago Manual of Style (16th Edition):

Taylor, Jessica. “High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Doctoral Dissertation, University of Manchester. Accessed January 23, 2021. https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321.

MLA Handbook (7th Edition):

Taylor, Jessica. “High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme.” 2019. Web. 23 Jan 2021.

Vancouver:

Taylor J. High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme. [Internet] [Doctoral dissertation]. University of Manchester; 2019. [cited 2021 Jan 23]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321.

Council of Science Editors:

Taylor J. High throughput screening of patient specific tumour cells : towards personalised treatment in recurrent glioblastoma multiforme. [Doctoral Dissertation]. University of Manchester; 2019. Available from: https://www.research.manchester.ac.uk/portal/en/theses/high-throughput-screening-of-patient-specific-tumour-cells-towards-personalised-treatment-in-recurrent-glioblastoma-multiforme(f4b3043c-faf0-4298-9b9f-2adb6a9577b6).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.809321

12. Dai, Yuheng. The Commercilazation of a Noval Antithrombotic Drug.

Degree: MSs, Biology, 2018, Case Western Reserve University School of Graduate Studies

 Thrombotic events are the main cause of morbidity and mortality in developed countries, and continue to be an important focus for new therapeutic research. A… (more)

Subjects/Keywords: Biology; Medicine; Thymidine phosphorylase, platelet, thrombosis, anti-platelet therapy, commercialization, drug repositioning, drug repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dai, Y. (2018). The Commercilazation of a Noval Antithrombotic Drug. (Masters Thesis). Case Western Reserve University School of Graduate Studies. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038

Chicago Manual of Style (16th Edition):

Dai, Yuheng. “The Commercilazation of a Noval Antithrombotic Drug.” 2018. Masters Thesis, Case Western Reserve University School of Graduate Studies. Accessed January 23, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038.

MLA Handbook (7th Edition):

Dai, Yuheng. “The Commercilazation of a Noval Antithrombotic Drug.” 2018. Web. 23 Jan 2021.

Vancouver:

Dai Y. The Commercilazation of a Noval Antithrombotic Drug. [Internet] [Masters thesis]. Case Western Reserve University School of Graduate Studies; 2018. [cited 2021 Jan 23]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038.

Council of Science Editors:

Dai Y. The Commercilazation of a Noval Antithrombotic Drug. [Masters Thesis]. Case Western Reserve University School of Graduate Studies; 2018. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1505303242046038


Leiden University

13. Frouws, M.A. Renewing clinical applications for commonly used medications in gastrointestinal cancer.

Degree: 2017, Leiden University

This thesis tried to unravel the epidemiological background of the current evidence on the effect of aspirin on gastrointestinal cancer. Advisors/Committee Members: Supervisor: C.J.H. van de Velde Co-Supervisors: G.J. Liefers, J.E.A. Portielje.

Subjects/Keywords: Aspirine; Drug repurposing; Gastrointestinal cancer; Aspirine; Drug repurposing; Gastrointestinal cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Frouws, M. A. (2017). Renewing clinical applications for commonly used medications in gastrointestinal cancer. (Doctoral Dissertation). Leiden University. Retrieved from http://hdl.handle.net/1887/55950

Chicago Manual of Style (16th Edition):

Frouws, M A. “Renewing clinical applications for commonly used medications in gastrointestinal cancer.” 2017. Doctoral Dissertation, Leiden University. Accessed January 23, 2021. http://hdl.handle.net/1887/55950.

MLA Handbook (7th Edition):

Frouws, M A. “Renewing clinical applications for commonly used medications in gastrointestinal cancer.” 2017. Web. 23 Jan 2021.

Vancouver:

Frouws MA. Renewing clinical applications for commonly used medications in gastrointestinal cancer. [Internet] [Doctoral dissertation]. Leiden University; 2017. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/1887/55950.

Council of Science Editors:

Frouws MA. Renewing clinical applications for commonly used medications in gastrointestinal cancer. [Doctoral Dissertation]. Leiden University; 2017. Available from: http://hdl.handle.net/1887/55950


University of Michigan

14. Truchan, Nathan. The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs.

Degree: PhD, Pharmaceutical Sciences, 2020, University of Michigan

 Triple negative breast cancer (TNBC) is known to be a highly heterogeneous disease and therefore more difficult to treat compared to other subtypes of breast… (more)

Subjects/Keywords: Triple Negative Breast Cancer; Cancer Stem Cells; Drug Repurposing; Heterogeneity; Science (General); Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Truchan, N. (2020). The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/155328

Chicago Manual of Style (16th Edition):

Truchan, Nathan. “The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs.” 2020. Doctoral Dissertation, University of Michigan. Accessed January 23, 2021. http://hdl.handle.net/2027.42/155328.

MLA Handbook (7th Edition):

Truchan, Nathan. “The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs.” 2020. Web. 23 Jan 2021.

Vancouver:

Truchan N. The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs. [Internet] [Doctoral dissertation]. University of Michigan; 2020. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/2027.42/155328.

Council of Science Editors:

Truchan N. The Origin of Intratumoral Heterogeneity in Triple Negative Breast Cancer Revealed and Eliminated by Repurposed FDA Approved Drugs. [Doctoral Dissertation]. University of Michigan; 2020. Available from: http://hdl.handle.net/2027.42/155328


University of the Western Cape

15. Omoruyi, Sylvester Ifeanyi. Investigating the anti-cancer activity of novel phenothiazines in glioblastoma .

Degree: 2018, University of the Western Cape

 Glioblastoma multiforme (GBM) remains the most malignant of all primary adult brain tumours. It is a highly invasive and vascularized neoplasm with limited treatment options… (more)

Subjects/Keywords: Drug repurposing; Phenothiazines; Chemotherapy; Anti-cancer agents; Cancer; Brain tumours; Glioblastoma; DNA damage; Apoptosis; Autophagy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Omoruyi, S. I. (2018). Investigating the anti-cancer activity of novel phenothiazines in glioblastoma . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/6329

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Omoruyi, Sylvester Ifeanyi. “Investigating the anti-cancer activity of novel phenothiazines in glioblastoma .” 2018. Thesis, University of the Western Cape. Accessed January 23, 2021. http://hdl.handle.net/11394/6329.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Omoruyi, Sylvester Ifeanyi. “Investigating the anti-cancer activity of novel phenothiazines in glioblastoma .” 2018. Web. 23 Jan 2021.

Vancouver:

Omoruyi SI. Investigating the anti-cancer activity of novel phenothiazines in glioblastoma . [Internet] [Thesis]. University of the Western Cape; 2018. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/11394/6329.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Omoruyi SI. Investigating the anti-cancer activity of novel phenothiazines in glioblastoma . [Thesis]. University of the Western Cape; 2018. Available from: http://hdl.handle.net/11394/6329

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

16. Hadwen, Jeremiah. Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation .

Degree: 2018, University of Ottawa

 Rare diseases caused by single-gene mutations affect almost one million Canadians. According to the Online Mendelian Inheritance in Man database, ~4,500 rare monogenic diseases have… (more)

Subjects/Keywords: Neurogenetics; Rare diseases; Drug repurposing

…Transcriptional drug repurposing to treat rare neurogenetic diseases 1 Rare monogenic diseases Rare… …view. Drug repurposing Repurposing clinically-tested small molecules and biologics has… …clinical effect, are prime targets for drug repurposing. Compared to new drug development, the… …early instances of drug repurposing occurred serendipitously because of unanticipated side… …effects. As drug repurposing research has gained momentum, more structured and efficient… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadwen, J. (2018). Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/37581

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hadwen, Jeremiah. “Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation .” 2018. Thesis, University of Ottawa. Accessed January 23, 2021. http://hdl.handle.net/10393/37581.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hadwen, Jeremiah. “Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation .” 2018. Web. 23 Jan 2021.

Vancouver:

Hadwen J. Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation . [Internet] [Thesis]. University of Ottawa; 2018. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/10393/37581.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hadwen J. Repurposing Clinic-Tested Drugs to Treat Rare Neurogenetic Diseases by Transcriptional Modulation . [Thesis]. University of Ottawa; 2018. Available from: http://hdl.handle.net/10393/37581

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. ADLER, NIKOLETTA. Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods.

Degree: School of Biochemistry & Immunology. Discipline of Biochemistry, 2018, Trinity College Dublin

 Human African Trypanosomiasis is a neglected parasitic disease caused by Trypanosoma brucei, which if left untreated eventually leads to coma and death. With no successful… (more)

Subjects/Keywords: anti-trypnosomal; cysteine protease inhibitor; drug repurposing; Fingolimod; S1P; SPK-843; Amphotericin B

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

ADLER, N. (2018). Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/82830

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

ADLER, NIKOLETTA. “Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods.” 2018. Thesis, Trinity College Dublin. Accessed January 23, 2021. http://hdl.handle.net/2262/82830.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

ADLER, NIKOLETTA. “Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods.” 2018. Web. 23 Jan 2021.

Vancouver:

ADLER N. Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods. [Internet] [Thesis]. Trinity College Dublin; 2018. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/2262/82830.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

ADLER N. Development of Novel Anti-Trypanosomal Compounds via Computational, In Vitro and In Vivo Methods. [Thesis]. Trinity College Dublin; 2018. Available from: http://hdl.handle.net/2262/82830

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Notre Dame

18. William T. Barker. Small Molecules That Synergize with Colistin</h1>.

Degree: Chemistry and Biochemistry, 2020, University of Notre Dame

  Antibiotic resistant bacteria pose an existential threat to the modern healthcare system. The degree and severity of antibiotic resistance that is clinically observed continually… (more)

Subjects/Keywords: Polymyxins; Organic Chemistry; Small Molecules; Antibiotic Resistant Bacteria; Colistin; Adjuvants; Drug Repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Barker, W. T. (2020). Small Molecules That Synergize with Colistin</h1>. (Thesis). University of Notre Dame. Retrieved from https://curate.nd.edu/show/db78tb12q6h

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Barker, William T.. “Small Molecules That Synergize with Colistin</h1>.” 2020. Thesis, University of Notre Dame. Accessed January 23, 2021. https://curate.nd.edu/show/db78tb12q6h.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Barker, William T.. “Small Molecules That Synergize with Colistin</h1>.” 2020. Web. 23 Jan 2021.

Vancouver:

Barker WT. Small Molecules That Synergize with Colistin</h1>. [Internet] [Thesis]. University of Notre Dame; 2020. [cited 2021 Jan 23]. Available from: https://curate.nd.edu/show/db78tb12q6h.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Barker WT. Small Molecules That Synergize with Colistin</h1>. [Thesis]. University of Notre Dame; 2020. Available from: https://curate.nd.edu/show/db78tb12q6h

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cincinnati

19. Patchala, Jagadeesh. Data Mining Algorithms for Discovering Patterns in Text Collections.

Degree: PhD, Engineering and Applied Science: Computer Science and Engineering, 2016, University of Cincinnati

 Discovering meta-information from collections of text documents is becoming an important research area due to increasing demands for automated analysis of large text collections. This… (more)

Subjects/Keywords: Computer Science; Authorship Analysis; Biclustering; 3-clusters; Drug repurposing; Text mining; Data mining

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Patchala, J. (2016). Data Mining Algorithms for Discovering Patterns in Text Collections. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372

Chicago Manual of Style (16th Edition):

Patchala, Jagadeesh. “Data Mining Algorithms for Discovering Patterns in Text Collections.” 2016. Doctoral Dissertation, University of Cincinnati. Accessed January 23, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372.

MLA Handbook (7th Edition):

Patchala, Jagadeesh. “Data Mining Algorithms for Discovering Patterns in Text Collections.” 2016. Web. 23 Jan 2021.

Vancouver:

Patchala J. Data Mining Algorithms for Discovering Patterns in Text Collections. [Internet] [Doctoral dissertation]. University of Cincinnati; 2016. [cited 2021 Jan 23]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372.

Council of Science Editors:

Patchala J. Data Mining Algorithms for Discovering Patterns in Text Collections. [Doctoral Dissertation]. University of Cincinnati; 2016. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1458299372


University of Illinois – Urbana-Champaign

20. Ostadhossein, Fatemeh. A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells.

Degree: MS, Bioengineering, 2015, University of Illinois – Urbana-Champaign

 Primary tumor extermination and conventional chemotherapy are proved to be inefficient in cancer therapy in that they preferentially abolish differentiated cells whilst leaving behind treatment… (more)

Subjects/Keywords: Cancer stem cell; STAT3 inhibition; Drug Delivery; Drug Repurposing; Carbon nanoparticles; Host guest chemistry; Cucurbitruil[6]; Niclosamide

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ostadhossein, F. (2015). A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells. (Thesis). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/89162

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ostadhossein, Fatemeh. “A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells.” 2015. Thesis, University of Illinois – Urbana-Champaign. Accessed January 23, 2021. http://hdl.handle.net/2142/89162.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ostadhossein, Fatemeh. “A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells.” 2015. Web. 23 Jan 2021.

Vancouver:

Ostadhossein F. A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells. [Internet] [Thesis]. University of Illinois – Urbana-Champaign; 2015. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/2142/89162.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ostadhossein F. A next generation theranostic nano-platform for sustained and enhanced inhibition of cancer stem cells. [Thesis]. University of Illinois – Urbana-Champaign; 2015. Available from: http://hdl.handle.net/2142/89162

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Kyoto University

21. SONI, SISWANTO. A drug repurposing study based on clinical big data for the treatment of interstitial lung disease .

Degree: 2020, Kyoto University

Subjects/Keywords: Drug repurposing; Drug repositioning; Interstitial lung disease; Amiodarone; Dabigatran

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

SONI, S. (2020). A drug repurposing study based on clinical big data for the treatment of interstitial lung disease . (Thesis). Kyoto University. Retrieved from http://hdl.handle.net/2433/259020

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

SONI, SISWANTO. “A drug repurposing study based on clinical big data for the treatment of interstitial lung disease .” 2020. Thesis, Kyoto University. Accessed January 23, 2021. http://hdl.handle.net/2433/259020.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

SONI, SISWANTO. “A drug repurposing study based on clinical big data for the treatment of interstitial lung disease .” 2020. Web. 23 Jan 2021.

Vancouver:

SONI S. A drug repurposing study based on clinical big data for the treatment of interstitial lung disease . [Internet] [Thesis]. Kyoto University; 2020. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/2433/259020.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

SONI S. A drug repurposing study based on clinical big data for the treatment of interstitial lung disease . [Thesis]. Kyoto University; 2020. Available from: http://hdl.handle.net/2433/259020

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

22. Rahman, Md Saifur. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells.

Degree: PhD, 2020, University of Cambridge

 The store-operated calcium entry (SOCE) pathway is an important route for generating cytosolic Ca2+ signals that regulate a diverse array of biological processes. Abnormal SOCE… (more)

Subjects/Keywords: Store operated calcium entry; SOCE blockers; Drug repurposing; OPCs; OPCS differentiation; multiple sclerosis; SOCE in OPCs

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rahman, M. S. (2020). Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/304875

Chicago Manual of Style (16th Edition):

Rahman, Md Saifur. “Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells.” 2020. Doctoral Dissertation, University of Cambridge. Accessed January 23, 2021. https://www.repository.cam.ac.uk/handle/1810/304875.

MLA Handbook (7th Edition):

Rahman, Md Saifur. “Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells.” 2020. Web. 23 Jan 2021.

Vancouver:

Rahman MS. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Jan 23]. Available from: https://www.repository.cam.ac.uk/handle/1810/304875.

Council of Science Editors:

Rahman MS. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/304875

23. Yousfi, Hanane. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals.

Degree: Docteur es, Maladies infectieuses, 2019, Aix Marseille Université

Les infections fongiques invasives constituent un sérieux problème de santé publique dans le monde ; cette situation se complique par la disponibilité d’un faible nombre… (more)

Subjects/Keywords: Résistance aux antimicrobiens; Antifongiques; Alternatives thérapeutiques; Repositionnement des médicaments; Antimicrobial-Resistance; Antifungals; Therapeutic alternatives; Drug-Repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yousfi, H. (2019). Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals. (Doctoral Dissertation). Aix Marseille Université. Retrieved from http://www.theses.fr/2019AIXM0234

Chicago Manual of Style (16th Edition):

Yousfi, Hanane. “Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals.” 2019. Doctoral Dissertation, Aix Marseille Université. Accessed January 23, 2021. http://www.theses.fr/2019AIXM0234.

MLA Handbook (7th Edition):

Yousfi, Hanane. “Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals.” 2019. Web. 23 Jan 2021.

Vancouver:

Yousfi H. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals. [Internet] [Doctoral dissertation]. Aix Marseille Université 2019. [cited 2021 Jan 23]. Available from: http://www.theses.fr/2019AIXM0234.

Council of Science Editors:

Yousfi H. Développement de nouvelles stratégies thérapeutiques pour pallier l'émergence de la résistance aux antifongiques : Innovative therapeutic alternatives to overcome the emergence of resistance to antifungals. [Doctoral Dissertation]. Aix Marseille Université 2019. Available from: http://www.theses.fr/2019AIXM0234


University of Sydney

24. El-Rashid, Mary. The use of drug repurposing to identify new treatment opportunities for kidney injury .

Degree: University of Sydney

 Aim: To determine the role of drug repurposing to treat kidney injury. Background: Acute kidney injury (AKI), is a major contributor to morbidity and mortality… (more)

Subjects/Keywords: AKI; CKD; colchicine; doxycycline; metformin; drug repurposing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

El-Rashid, M. (n.d.). The use of drug repurposing to identify new treatment opportunities for kidney injury . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/22327

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

El-Rashid, Mary. “The use of drug repurposing to identify new treatment opportunities for kidney injury .” Thesis, University of Sydney. Accessed January 23, 2021. http://hdl.handle.net/2123/22327.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

El-Rashid, Mary. “The use of drug repurposing to identify new treatment opportunities for kidney injury .” Web. 23 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

El-Rashid M. The use of drug repurposing to identify new treatment opportunities for kidney injury . [Internet] [Thesis]. University of Sydney; [cited 2021 Jan 23]. Available from: http://hdl.handle.net/2123/22327.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

El-Rashid M. The use of drug repurposing to identify new treatment opportunities for kidney injury . [Thesis]. University of Sydney; Available from: http://hdl.handle.net/2123/22327

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Purdue University

25. Thangamani, Shankar. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.

Degree: PhD, 2016, Purdue University

  Bacterial and fungal resistance to conventional antimicrobials is a burgeoning global health epidemic that necessitates urgent action. Even more alarming, the development of new… (more)

Subjects/Keywords: Biological sciences; Health and environmental sciences; Antimicrobial resistance; Approved drugs; Bacteria; Drug discovery; Fungi; Repurposing; Immunology and Infectious Disease; Microbiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thangamani, S. (2016). Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. (Doctoral Dissertation). Purdue University. Retrieved from https://docs.lib.purdue.edu/open_access_dissertations/1015

Chicago Manual of Style (16th Edition):

Thangamani, Shankar. “Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.” 2016. Doctoral Dissertation, Purdue University. Accessed January 23, 2021. https://docs.lib.purdue.edu/open_access_dissertations/1015.

MLA Handbook (7th Edition):

Thangamani, Shankar. “Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections.” 2016. Web. 23 Jan 2021.

Vancouver:

Thangamani S. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. [Internet] [Doctoral dissertation]. Purdue University; 2016. [cited 2021 Jan 23]. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1015.

Council of Science Editors:

Thangamani S. Repurposing non-antimicrobial drugs to treat multi-drug resistant bacterial and fungal infections. [Doctoral Dissertation]. Purdue University; 2016. Available from: https://docs.lib.purdue.edu/open_access_dissertations/1015


University of Vienna

26. Gurinova, Jana. Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates.

Degree: 2018, University of Vienna

 Seltene Erkrankungen betreffen weltweit über 400 Millionen Menschen. Sie werden über ihre Häufigkeit beziehungsweise ihre Seltenheit definiert, und daher zwangsläufig auch über eine geringe Zahl… (more)

Subjects/Keywords: 44.42 Pharmazeutische Chemie; 44.40 Pharmazie, Pharmazeutika; 44.48 Medizinische Genetik; seltene Erkrankungen / KNIME / Workflow / Data-Mining / Neupositionierung; orphan diseases / rare diseases / KNIME / workflow / data mining / drug repurposing / drug repositioning

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gurinova, J. (2018). Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/55364/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gurinova, Jana. “Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates.” 2018. Thesis, University of Vienna. Accessed January 23, 2021. http://othes.univie.ac.at/55364/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gurinova, Jana. “Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates.” 2018. Web. 23 Jan 2021.

Vancouver:

Gurinova J. Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates. [Internet] [Thesis]. University of Vienna; 2018. [cited 2021 Jan 23]. Available from: http://othes.univie.ac.at/55364/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gurinova J. Development of a KNIME workflow for the retrieval of associations between orphan diseases and their possible drug repurposing candidates. [Thesis]. University of Vienna; 2018. Available from: http://othes.univie.ac.at/55364/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. Blankstein, Anna R. Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells.

Degree: Biochemistry and Medical Genetics, 2017, University of Manitoba

 In cancer cells, the most common forms of cell death are often actively inhibited, contributing to the development of drug resistance. Identifying and exploiting alternative… (more)

Subjects/Keywords: Cell death; Ferroptosis; Glioblastoma; Lung adenocarcinoma; Drug synergy; Drug repurposing

…acid Bovine serum albumin Cationic amphiphilic drug Combination index Chronic lymphocytic… …Fetal bovine serum Food and Drug Administration Ferrostatin-1 Ferroptosis-inducing compound… …x28;37). In 2015, the United States Food and Drug Administration (FDA) approved… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Blankstein, A. R. (2017). Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/32404

Chicago Manual of Style (16th Edition):

Blankstein, Anna R. “Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells.” 2017. Masters Thesis, University of Manitoba. Accessed January 23, 2021. http://hdl.handle.net/1993/32404.

MLA Handbook (7th Edition):

Blankstein, Anna R. “Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells.” 2017. Web. 23 Jan 2021.

Vancouver:

Blankstein AR. Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells. [Internet] [Masters thesis]. University of Manitoba; 2017. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/1993/32404.

Council of Science Editors:

Blankstein AR. Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells. [Masters Thesis]. University of Manitoba; 2017. Available from: http://hdl.handle.net/1993/32404

28. Dhara, Roopesh. COMPUTATIONAL DRUG REPURPOSING FOR BREAST CANCER SUBTYPES.

Degree: MS, Computer Science, 2019, University of Windsor

 Breast cancer makes up 25 percent of all new cancer diagnoses globally according to the American Cancer Society(ACS). Developing a highly effective drug can be… (more)

Subjects/Keywords: breast cancer; clustering; drug repositioning; drug repurposing; machine learning; pharmacology

…Traditional drug discovery and development process . . . . . . 2 1.1.3 What is drug repurposing… …Drug Repurposing 1 viii 1.6 Thesis Organization… …2 Literature Review 2.1 Existing approaches on drug repurposing… …2.1.1 3 Proposed Methods 3.2 3.3 10 11 A new computational drug repurposing method using… …paradigm: Dr Insight empowers signature free, enhanced drug repurposing… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dhara, R. (2019). COMPUTATIONAL DRUG REPURPOSING FOR BREAST CANCER SUBTYPES. (Masters Thesis). University of Windsor. Retrieved from https://scholar.uwindsor.ca/etd/7696

Chicago Manual of Style (16th Edition):

Dhara, Roopesh. “COMPUTATIONAL DRUG REPURPOSING FOR BREAST CANCER SUBTYPES.” 2019. Masters Thesis, University of Windsor. Accessed January 23, 2021. https://scholar.uwindsor.ca/etd/7696.

MLA Handbook (7th Edition):

Dhara, Roopesh. “COMPUTATIONAL DRUG REPURPOSING FOR BREAST CANCER SUBTYPES.” 2019. Web. 23 Jan 2021.

Vancouver:

Dhara R. COMPUTATIONAL DRUG REPURPOSING FOR BREAST CANCER SUBTYPES. [Internet] [Masters thesis]. University of Windsor; 2019. [cited 2021 Jan 23]. Available from: https://scholar.uwindsor.ca/etd/7696.

Council of Science Editors:

Dhara R. COMPUTATIONAL DRUG REPURPOSING FOR BREAST CANCER SUBTYPES. [Masters Thesis]. University of Windsor; 2019. Available from: https://scholar.uwindsor.ca/etd/7696


University of Michigan

29. Murashov, Mikhail. Pharmaceutical Impact of the Different Ionization States of a Weakly Basic Drug within a Living Organism.

Degree: PhD, Pharmaceutical Sciences, 2019, University of Michigan

 Clofazimine (CFZ), an oral FDA-approved antibiotic for over 40 years, has been used effectively against leprosy and multi-drug resistant tuberculosis (MDR-TB). Due to its atypical… (more)

Subjects/Keywords: ionization states of a weakly basic drug within a living organism; physicochemical parameters of clofazimine; clofazimine drug biocrystals within tissue macrophages; clofazimine-induced skin pigmentation, adverse drug reaction; biomimetic formulation of micronized drug crystals; clofazimine reformulation and repurposing; Pharmacy and Pharmacology; Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Murashov, M. (2019). Pharmaceutical Impact of the Different Ionization States of a Weakly Basic Drug within a Living Organism. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/149961

Chicago Manual of Style (16th Edition):

Murashov, Mikhail. “Pharmaceutical Impact of the Different Ionization States of a Weakly Basic Drug within a Living Organism.” 2019. Doctoral Dissertation, University of Michigan. Accessed January 23, 2021. http://hdl.handle.net/2027.42/149961.

MLA Handbook (7th Edition):

Murashov, Mikhail. “Pharmaceutical Impact of the Different Ionization States of a Weakly Basic Drug within a Living Organism.” 2019. Web. 23 Jan 2021.

Vancouver:

Murashov M. Pharmaceutical Impact of the Different Ionization States of a Weakly Basic Drug within a Living Organism. [Internet] [Doctoral dissertation]. University of Michigan; 2019. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/2027.42/149961.

Council of Science Editors:

Murashov M. Pharmaceutical Impact of the Different Ionization States of a Weakly Basic Drug within a Living Organism. [Doctoral Dissertation]. University of Michigan; 2019. Available from: http://hdl.handle.net/2027.42/149961

30. Σιαβέλης, Ιωάννης. Μέθοδοι βιοπληροφορικής για τον επαναπροσδιορισμό φαρμάκων στη νόσο Αλτσχάιμερ.

Degree: 2015, University of Patras

Η νόσος Αλτσχάιμερ καταλαμβάνει την πρωτοκαθεδρία στις μη αναστρέψιμες άνοιες με τους επιδημιολογικούς της δείκτες να αυξάνονται όσο μεγαλώνει το προσδόκιμο ζωής του ανθρώπου. Η… (more)

Subjects/Keywords: Νόσος Αλτσχάιμερ; Επαναστόχευση φαρμάκων; Βιοπληροφορική; Μικροσυστοιχίες; Διαφορική έκφραση γονιδίων; 616.831 061; Alzheimer’s disease; Drug repurposing; Bioinformatics; Microarrays; Connectivity map; Differential gene expression

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Σιαβέλης, . (2015). Μέθοδοι βιοπληροφορικής για τον επαναπροσδιορισμό φαρμάκων στη νόσο Αλτσχάιμερ. (Masters Thesis). University of Patras. Retrieved from http://hdl.handle.net/10889/8782

Chicago Manual of Style (16th Edition):

Σιαβέλης, Ιωάννης. “Μέθοδοι βιοπληροφορικής για τον επαναπροσδιορισμό φαρμάκων στη νόσο Αλτσχάιμερ.” 2015. Masters Thesis, University of Patras. Accessed January 23, 2021. http://hdl.handle.net/10889/8782.

MLA Handbook (7th Edition):

Σιαβέλης, Ιωάννης. “Μέθοδοι βιοπληροφορικής για τον επαναπροσδιορισμό φαρμάκων στη νόσο Αλτσχάιμερ.” 2015. Web. 23 Jan 2021.

Vancouver:

Σιαβέλης . Μέθοδοι βιοπληροφορικής για τον επαναπροσδιορισμό φαρμάκων στη νόσο Αλτσχάιμερ. [Internet] [Masters thesis]. University of Patras; 2015. [cited 2021 Jan 23]. Available from: http://hdl.handle.net/10889/8782.

Council of Science Editors:

Σιαβέλης . Μέθοδοι βιοπληροφορικής για τον επαναπροσδιορισμό φαρμάκων στη νόσο Αλτσχάιμερ. [Masters Thesis]. University of Patras; 2015. Available from: http://hdl.handle.net/10889/8782

[1] [2]

.